Christopher Yue Kwong Lui
雷宇光
This page summarises the Hong Kong Securities and Futures Commission (SFC) public register record for Christopher Yue Kwong Lui (雷宇光), a licensed Responsible Officer with CE reference AOS677. Currently licensed at 1 firm(s): Violux Research Limited. Active regulated activities: Type 4 - Advising on securities. This person has 16.1 years of SFC licence history. Total licence records on file: 12.
Information
- LinkedIn:
- Email:
Licence history
| Firm | Role | Regulated activity | From | To |
|---|---|---|---|---|
| Violux Research Limited 紫光研究所有限公司 |
RO | Type 4 - Advising on securities | 2026-02-13 | present |
| Jefferies Hong Kong Limited 富瑞金融集團香港有限公司 |
Rep | Type 4 - Advising on securities | 2020-03-23 | 2024-10-28 |
| Fosun International Securities Limited 復星國際證券有限公司 |
Rep | Type 1 - Dealing in securities | 2019-09-05 | 2020-03-06 |
| Fosun International Securities Limited 復星國際證券有限公司 |
Rep | Type 4 - Advising on securities | 2019-08-23 | 2020-03-06 |
| China Renaissance Securities (Hong Kong) Limited 華興證券(香港)有限公司 |
Rep | Type 4 - Advising on securities | 2017-09-26 | 2019-05-16 |
| Sectoral Asset Management Limited | Rep | Type 1 - Dealing in securities | 2016-01-05 | 2017-02-27 |
| Sectoral Asset Management Limited | Rep | Type 4 - Advising on securities | 2016-01-05 | 2017-02-27 |
| CGS International Securities Hong Kong Limited 中國銀河證券香港有限公司 |
Rep | Type 4 - Advising on securities | 2014-08-22 | 2015-10-31 |
| BOCOM International Securities Limited 交銀國際證券有限公司 |
Rep | Type 4 - Advising on securities | 2013-07-25 | 2014-07-18 |
| Morgan Stanley Asia Limited 摩根士丹利亞洲有限公司 |
Rep | Type 1 - Dealing in securities | 2008-05-05 | 2013-01-15 |
| Morgan Stanley Asia Limited 摩根士丹利亞洲有限公司 |
Rep | Type 4 - Advising on securities | 2008-05-05 | 2013-01-15 |
| Merrill Lynch (Asia Pacific) Limited | Rep | Type 1 - Dealing in securities | 2007-03-28 | 2008-01-22 |
Worked alongside
The 20 closest colleagues, strongest tie first — individuals licensed at the same firm as Christopher Yue Kwong Lui during overlapping periods. Ranked by how long they overlapped and how similar their regulated activities were, with shared time at a smaller firm weighted more than at a large one. See the detailed formula.